Sheaff Brock Investment Advisors, LLC Madrigal Pharmaceuticals, Inc. Transaction History
Sheaff Brock Investment Advisors, LLC
- $1.13 Billion
- Q3 2024
A detailed history of Sheaff Brock Investment Advisors, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Sheaff Brock Investment Advisors, LLC holds 3,500 shares of MDGL stock, worth $1.19 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,500
Previous 3,500
-0.0%
Holding current value
$1.19 Million
Previous $980,000
24.29%
% of portfolio
0.07%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding MDGL
# of Institutions
296Shares Held
22MCall Options Held
819KPut Options Held
640K-
Janus Henderson Group PLC London, X02.48MShares$840 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$692 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$688 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$676 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$669 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.8B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...